HIA
ONC icon

Harbor Investment Advisory’s BeOne Medicines Ltd ONC Stock Holding History

Harbor Investment Advisory’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$458K Buy
+1,251
New +$428K 0.03% 313
2023
Q3 		– Sell
-77
Closed -$13.7K – 1365
2023
Q2 		$13.7K Hold
77
– – ﹤0.01% 971
2023
Q1 		$16.6K Hold
77
– – ﹤0.01% 942
2022
Q4 		$16.9K Hold
77
– – ﹤0.01% 927
2022
Q3 		$10K Hold
77
– – ﹤0.01% 1049
2022
Q2 		$12K Hold
77
– – ﹤0.01% 1008
2022
Q1 		$15K Hold
77
– – ﹤0.01% 997
2021
Q4 		$21K Hold
77
– – ﹤0.01% 926
2021
Q3 		$28K Hold
77
– – ﹤0.01% 895
2021
Q2 		$26K Hold
77
– – ﹤0.01% 864
2021
Q1 		$27K Hold
77
– – ﹤0.01% 830
2020
Q4 		$20K Buy
+77
New +$21.2K ﹤0.01% 829

Other funds holding ONC

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Harbor Investment Advisory's ONC Position: Q3 2026 in Review

Harbor Investment Advisory opened a new position in BeOne Medicines Ltd (ONC) in Q3 2026: 1,251 shares worth $458K. The stake represents 0.03% of the portfolio and ranks #313 among its holdings. This is a return to the name: Harbor Investment Advisory previously reported a position in ONC as recently as Q2 2023.

Harbor Investment Advisory first reported a position in ONC in Q4 2020 and has held it in 12 quarters since. 6 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Harbor Investment Advisory held 1,251 shares of BeOne Medicines Ltd worth $458K as of Q3 2026.
  • BeOne Medicines Ltd was a new Harbor Investment Advisory position in Q3 2026.
  • BeOne Medicines Ltd made up 0.03% of Harbor Investment Advisory's portfolio in Q3 2026, its #313 holding.
  • Harbor Investment Advisory first reported a position in BeOne Medicines Ltd in Q4 2020 and has held it in 12 quarters since.
  • 6 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Harbor Investment Advisory's 13F filing for Q3 2026, filed 13 Oct 2026.